日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System

新的经验证的轻链(AL)淀粉样变性分期系统,其中IIIC期定义了超高危:AL国际分期系统

Khwaja, Jahanzaib; Kirkwood, Amy A; Milani, Paolo; Yohannan, Binoy; Theodorakakou, Foteini; Weverling, Flores; Di Simone, Valeria; Ravichandran, Sriram; Kumar, Shaji; Petropoulos, Ioannis; Mussinelli, Roberta; Cohen, Oliver; Oerlemans, Marish I F J; Muchtar, Eli; Stamatelopoulos, Kimon; Lachmann, Helen J; Gillmore, Julian D; Briasoulis, Alexandros; Gertz, Morie; Whelan, Carol; Venneri, Lucia; Fontana, Marianna; Mahmood, Shameem; Schwotzer, Rahel; Minnema, Monique C; Dispenzieri, Angela; Palladini, Giovanni; Kastritis, Efstathios; Wechalekar, Ashutosh

Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience

慢性淋巴细胞白血病(CLL)里氏转化患者的中枢神经系统受累:梅奥诊所的经验

Baccon, Domitilla; Atallah-Yunes, Suheil Albert; Hampel, Paul J; Roeker, Lindsey E; Kenderian, Saad S; Muchtar, Eli; Kay, Neil E; Koehler, Amber B; Behnken, Amy L; Wagner, Catherine C; Johnston, Patrick B; Nowakowski, Grzegorz S; Habermann, Thomas M; Hilal, Talal; Tsang, Mazie; Leis, Jose F; Rosenthal, Allison C; Parrondo, Ricardo D; Tun, Han W; Shi, Min; King, Rebecca L; He, Rong; Parikh, Sameer A; Wang, Yucai

Proteomic shifts post-plasma cell therapy in AL amyloid plaques and potential implications for light chaindirected anti-fibril monoclonal antibodies

AL淀粉样斑块经浆细胞治疗后蛋白质组的变化及其对轻链导向抗原纤维单克隆抗体的潜在影响

Rees, Matthew J; Dasari, Surendra; McPhail, Ellen D; Dispenzieri, Angela; Charlesworth, Cristine M; Muchtar, Eli; Gertz, Morie; Gupta, Navin; Anderson, Emilie; Quang, Samantha N; Dick, Christopher; Kumar, Shaji; Kourelis, Taxiarchis

Concurrent Sporadic Late-Onset Nemaline Myopathy and an Excessive Glycogen Accumulation Associated With Monoclonal Gammopathy

同时患有散发性迟发性线状肌病和单克隆丙种球蛋白病相关的糖原过度积累

Jones, Felipe J S; Cheema, Ikreet; Laughlin, Ruple S; Muchtar, Eli; Liewluck, Teerin

Assessing the Reliability of Lung Ultrasound in Neonatal Acute Care Setting: A Systematic Review Protocol

评估肺部超声在新生儿急症护理环境中的可靠性:系统评价方案

Nawawi, Yusuf Syaeful; Hanafi, Muchtar; Firdaus, Zaka Jauhar; Adhie, Anistyaning Wahyu

Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era

AL淀粉样变性血液学反应动力学:达雷妥尤单抗时代临床和细胞遗传学亚组分析的启示

Bazarbachi, Abdul-Hamid; Zanwar, Saurabh; Hegenbart, Ute; Trajanova, Despina; Bhutani, Divaya; Gertz, Morie A; Dispenzieri, Angela; Kumar, Shaji; D'Souza, Anita; Patwari, Anannya; Cowan, Andrew; Chen, GuiZhen; Milani, Paolo; Palladini, Giovanni; Sanchorawala, Vaishali; Bodanapu, Geethika; Mohty, Mohamad; Lentzsch, Suzanne; Schönland, Stefan O; Muchtar, Eli; Chakraborty, Rajshekhar

Biomarkers to Predict Abnormal Technetium-99m Pyrophosphate Scans in Patients With Suspected Transthyretin Amyloidosis

用于预测疑似转甲状腺素蛋白淀粉样变性患者异常锝-99m焦磷酸盐扫描结果的生物标志物

De Michieli, Laura; AbouEzzeddine, Omar F; Abbasi, Muhannad A; Davies, Daniel R; Scott, Christopher G; Muchtar, Eli; Dispenzieri, Angela; Grogan, Martha; Redfield, Margaret M; Jaffe, Allan S

The FLC Ratio Reframed: Averting Unnecessary Heart Biopsies in Wild-Type ATTR Amyloidosis

重新定义 FLC 比率:避免野生型 ATTR 淀粉样变性患者进行不必要的心脏活检

Muchtar, Eli; Maurer, Mathew S

Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma

合成期克隆性浆细胞比例可识别多发性骨髓瘤中独特的高危人群。

Zanwar, Saurabh; Jevremovic, Dragan; Kapoor, Prashant; Olteanu, Horatiu; Buadi, Francis; Horna, Pedro; Gonsalves, Wilson; Otteson, Gregory; Bolarinwa, Abiola Bukunmi; Hayman, Suzanne; Abdallah, Nadine; Binder, Moritz; Cook, Joselle; Dispenzieri, Angela; Dingli, David; Gertz, Morie A; Kourelis, Taxiarchis; Leung, Nelson; Lin, Yi; Muchtar, Eli; Warsame, Rahma; Fonder, Amie; Hobbs, Miriam; Hwa, Yi Lisa; Rogers, Michelle; Kyle, Robert A; Rajkumar, S Vincent; Kumar, Shaji

Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes

维奈托克联合治疗方案在复发/难治性多发性骨髓瘤中的应用:临床实践模式及继发性细胞遗传学异常对治疗结果的影响

Bolarinwa, Abiola; Nagaraj, Madhu; Zanwar, Saurabh; Abdallah, Nadine; Bergsagel, P Leif; Binder, Moritz; Buadi, Francis; Chhabra, Saurabh; Cook, Joselle; Dingli, David; Dispenzieri, Angela; Gertz, Morie A; Gonsalves, Wilson; Hayman, Suzanne; Kapoor, Prashant; Kourelis, Taxiarchis; Leung, Nelson; Lin, Yi; Muchtar, Eli; Parrondo, Ricardo; Roy, Vivek; Sher, Taimur; Siddiqui, Mustaqeem; Warsame, Rahma; Fonder, Amie; Hobbs, Miriam; Hwa, Yi Lisa; Rogers, Michelle; Yadav, Udit; Wiedmeier-Nutor, J Erin; Baughn, Linda B; Vincent Rajkumar, S; Fonseca, Rafael; Ailawadhi, Sikander; Kumar, Shaji